rs932032926
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000080.4(CHRNE):c.1072_1091delCCGCCGCCCGAGGCCCCCCG(p.Pro358GlyfsTer32) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000064 in 1,562,788 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P358P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000080.4 frameshift
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRNE | NM_000080.4 | c.1072_1091delCCGCCGCCCGAGGCCCCCCG | p.Pro358GlyfsTer32 | frameshift_variant | Exon 10 of 12 | ENST00000649488.2 | NP_000071.1 | |
| C17orf107 | NM_001145536.2 | c.-437_-418delCGGGGGGCCTCGGGCGGCGG | upstream_gene_variant | ENST00000381365.4 | NP_001139008.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHRNE | ENST00000649488.2 | c.1072_1091delCCGCCGCCCGAGGCCCCCCG | p.Pro358GlyfsTer32 | frameshift_variant | Exon 10 of 12 | NM_000080.4 | ENSP00000497829.1 | |||
| C17orf107 | ENST00000381365.4 | c.-437_-418delCGGGGGGCCTCGGGCGGCGG | upstream_gene_variant | 2 | NM_001145536.2 | ENSP00000370770.3 |
Frequencies
GnomAD3 genomes AF: 0.00000665 AC: 1AN: 150314Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000593 AC: 1AN: 168526 AF XY: 0.0000106 show subpopulations
GnomAD4 exome AF: 0.00000637 AC: 9AN: 1412474Hom.: 0 AF XY: 0.00000571 AC XY: 4AN XY: 700108 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000665 AC: 1AN: 150314Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73414 show subpopulations
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 4A Pathogenic:2
- -
This sequence change creates a premature translational stop signal (p.Pro358Glyfs*32) in the CHRNE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHRNE are known to be pathogenic (PMID: 22678886). This variant is present in population databases (no rsID available, gnomAD 0.001%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. ClinVar contains an entry for this variant (Variation ID: 534252). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense-mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -
CHRNE-related disorder Pathogenic:1
The CHRNE c.1072_1091del20 variant is predicted to result in a frameshift and premature protein termination (p.Pro358Glyfs*32). To our knowledge, this variant has not been reported in the literature. However, at PreventionGenetics we have observed this variant in the homozygous state in two other patients presenting with myasthenic syndrome phenotypes. This variant is reported in 0.0014% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in CHRNE are expected to be pathogenic. This variant is interpreted as likely pathogenic. -
Congenital myasthenic syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at